Proof of Principle Program Phase 1

Results of the 01/11/2007 200711PPP Proof of Principle Program Competition
Updated : 26/05/2008
Principal Investigators
Institution Paid
Research Institution*
Title
Co-Applicant(s), Associate(s)/
Institution
Funding Term Status
CULLIS, Pieter R - University of British Columbia
$148,015 1 Yr(s)
BALLY, Marcel B - University of British Columbia
CIUFOLINI, Marco A - University of British Columbia
University of British Columbia
Liposomal nanoparticle formulation of the anticancer agent docetaxel
FINLAY, Barton B - University of British Columbia
$138,000 1 Yr(s)
University of British Columbia
Development of a Salmonella Poultry and Human Vaccine based on Secreted Bacterial Products
* "Research Institution" is displayed only when it is different from "Institution Paid".
1

Principal Investigators
Institution Paid
Research Institution*
Title
Co-Applicant(s), Associate(s)/
Institution
Funding Term Status
FOLDVARI, Marianna - University of Waterloo (Ontario)
$150,000 1 Yr(s)
BADEA, Ildiko - University of Saskatchewan
VERRALL, Ronald E - University of Saskatchewan
WETTIG, Shawn D - University of Waterloo (Ontario)
University of Waterloo (Ontario)
Development of gemini nanoparticles for non- viral gene delivery
GORSKI, Sharon M - B.C. Cancer Research Centre (Vancouver)
BALLY, Marcel BBC Cancer Agency (Vancouver, BC)
$150,000 1 Yr(s)
University of British Columbia
B.C. Cancer Research Centre (Vancouver)
Novel compositions and methods for improving response to anticancer therapies
* "Research Institution" is displayed only when it is different from "Institution Paid".
2

Principal Investigators
Institution Paid
Research Institution*
Title
Co-Applicant(s), Associate(s)/
Institution
Funding Term Status
HEBERT, Marie-Josée - Hôpital Notre-Dame (Montréal)
BROPHY, James MMcGill University/Université McGillCARDINAL, HéloiseCentre Hosp. de l'Université de Montréal (CHUM)DENDUKURI, NandiniMcGill University/Université McGillMADORE, FrançoisHôpital du Sacré- Coeur de Montréal
$150,000 1 Yr(s)
Centre Hosp. de l'Université de Montréal (CHUM)
Hôpital Notre-Dame (Montréal)
Validation of sFAS measurement for the diagnosis of acute coronary syndrome
HUMPHRIES, R. K - B.C. Cancer Research Centre (Vancouver)
$138,655 1 Yr(s)
University of British Columbia
B.C. Cancer Research Centre (Vancouver)
MicroRNAs as therapeutic agents in acute myeloid leukemia
JEAN, François - University of British Columbia
$150,000 1 Yr(s)
University of British Columbia
Developing a new class of non-competitive hepatitis C virus (HCV)NS3/NS4A protease inhibitors as anti-HCV agents
* "Research Institution" is displayed only when it is different from "Institution Paid".
3

Principal Investigators
Institution Paid
Research Institution*
Title
Co-Applicant(s), Associate(s)/
Institution
Funding Term Status
KUMAR, Rakesh - University of Alberta
KUNIMOTO, Dennis YUniversity of Alberta
$149,500 1 Yr(s)
University of Alberta
Development of novel inhibitors for the treatment of Tuberculosis (TB) infections
LAJOIE, Gilles A - University of Western Ontario
HAN, Victor Khin MUniversity of Western Ontario
$149,800 1 Yr(s)
University of Western Ontario
Validation of Biomarkers for Preeclampsia
MEDIN, Jeffrey A - University Health Network (Toronto)
PAIGE, Christopher JUniversity Health Network (Toronto)
$150,000 1 Yr(s)
University Health Network (Toronto)
Localized IL-12 Immunotherapy For CML
MISHRA, Ram K - McMaster University
GABRIELE, Joseph PMcMaster University
$150,000 1 Yr(s)
McMaster University
Use of a Catecholamine Regulated Protein (CRP40) in the Development and Commercialization of a Blood Test for the Early Diagnosis of Parkinson's Disease and Schizophrenia
* "Research Institution" is displayed only when it is different from "Institution Paid".
4

Principal Investigators
Institution Paid
Research Institution*
Title
Co-Applicant(s), Associate(s)/
Institution
Funding Term Status
OUELLETTE, Marc - Université Laval
$150,000 1 Yr(s)
DRUMMELSMITH, Jolyne Y - Université Laval
Université Laval
Centre hospitalier de l'Université Laval (Québec)
Molecular detection of vancomycin- intermediate Staphylococcus aureus (VISA)
PARK, Morag - McGill University
HALLETT, Michael TMcGill University/Université McGill
$148,421 1 Yr(s)
McGill University
Royal Victoria Hospital (Montreal)
Development of a clinical test based on a multigene predictor of outcome for breast cancer
TSAO, Ming-Sound - University Health Network (Toronto)
DER, Sandy DUniversity of TorontoJURISICA, IgorOntario Cancer Institute (Toronto)PINTILIE, MelaniaPrincess Margaret Hospital (Toronto)
$150,000 1 Yr(s)
University Health Network (Toronto)
Ontario Cancer Institute (Toronto)
A Clinical Test for Lung Cancer using Prognostic Gene Classifiers
* "Research Institution" is displayed only when it is different from "Institution Paid".
5

Principal Investigators
Institution Paid
Research Institution*
Title
Co-Applicant(s), Associate(s)/
Institution
Funding Term Status
WHITE, John H - McGill University
MADER, Sylvie NUniversité de Montréal
$150,000 1 Yr(s)
GLEASON, James L - McGill University
McGill University
Analysis of efficacy and specificity of hybrid molecules combining vitamin D receptor agonism and histone deacetylase inhibition
WU, Jiangping - Centre Hosp. de l'Université de Montréal (CHUM)
$150,000 1 Yr(s)
Centre Hosp. de l'Université de Montréal (CHUM)
Identification of novel proteasome inhibitors as drug leads for cancer and immunological diseases
* "Research Institution" is displayed only when it is different from "Institution Paid".
6